David A. Siegel Prime Medicine, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 119,900 shares of PRME stock, worth $330,924. This represents 0.0% of its overall portfolio holdings.

Number of Shares

119,900

Previous 176,500 32.07%

Holding current value

$330,924

Previous $907,000 48.84%

% of portfolio

0.0%

Previous 0.0%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.41 - $6.7 $193,006 - $379,220	-56,600 Reduced 32.07%	119,900 $464,000
Q2 2024 Aug 14, 2024	BUY	$4.3 - $8.03 $53,750 - $100,374	12,500 Added 7.62%	176,500 $907,000
Q1 2024 May 15, 2024	BUY	$6.35 - $9.39 $749,300 - $1.11 Million	118,000 Added 256.52%	164,000 $1.15 Million
Q4 2023 Feb 14, 2024	BUY	$5.59 - $9.55 $257,140 - $439,300	46,000 New	46,000 $407,000

Others Institutions Holding PRME

# of Institutions

123

Shares Held

64.7M

Call Options Held

324K

Put Options Held

64.4K

View Full List

About Prime Medicine, Inc.

Ticker PRME
Shares Outstandng 95,730,200
Market Cap $264M

More about PRME

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account